Scolaris Content Display Scolaris Content Display

Educación individual del paciente con diabetes mellitus tipo 2

Contraer todo Desplegar todo

Referencias

Referencias de los estudios incluidos en esta revisión

Campbell 1996 {published data only}

Campbell E M, Redman S, Moffitt PS, Sanson‐Fisher RW. The relative effectiveness of educational and behavioral instruction programs for patients with NIDDM: a randomized trial. Diabetes Educator 1996;22(4):379‐86.

Dalmau 2003 {published data only}

Dalmau Llorca MR, Garcia Bernal G, Aguilar Martin C, Palau Galindo A. [Group versus individual education for type‐2 diabetes patients]. Atencion Primaria 2003;32(1):36‐41.

Goudswaard 2004 {published data only}

Goudswaard AN, Stolk RP, Zuithoff NP, de Valk HW, Rutten GE. Long‐term effects of self‐management education for patients with Type 2 diabetes taking maximal oral hypoglycaemic therapy: a randomized trial in primary care. Diabetic Medicine 2004;21(5):491‐6.

Hawthorne 1997 {published data only}

Hawthorne K, Tomlinson S. One‐to‐one teaching with pictures‐ flashcard health education for Bristish Asians with diabetes. British Journal of General Practice 1997;47:301‐304.

Hiss 2001 {published data only}

Hiss RG, Lou Gillard M, Armbruster BA, McClure LA. Comprehensive evaluation of community‐based diabetic patients: Effect of feedback to patients and their physicians: A randomized controlled trial. Diabetes Care 2001;24(4):690‐4.

Ko 2004 {published data only}

Ko GTC, Li JKY, Kan ECY, Lo MKW. Effects of a structured health education programme by a diabetic education nurse on cardiovascular risk factors in Chinese Type 2 diabetic patients: a 1‐year prospective randomized study. Diabetic Medicine 2004;21:1274‐1279.

Rickheim 2002 {published data only}

Rickheim PL, Weaver TW, Flader JL, Kendall DM. Assessment of group versus individual diabetes education: a randomized study. Diabetes Care 2002;25(2):269‐74.

Shibayama 2007 {published data only}

Shibayama T, Kobayashi K, Takano A, Kadowaki T, Kazuma K. Effectiveness of lifestyle counseling by certified expert nurse of Japan for non‐insulin‐treated diabetic outpatients: A 1‐year randomized controlled trial. Diabetes Research and Clinical Practice 2007;76:265‐268.

Whittemore 2004 {published data only}

Whittemore R, Melkus GD, Sullivan A, Grey M. A nurse‐coaching intervention for women with type 2 diabetes. Diabetes Educator 2004;30(5):795‐804.

Referencias de los estudios excluidos de esta revisión

Aas 2005 {published data only}

Aas, A M, I. Bergstad, et al. An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study. Diabetic Medicine 2005;22(3):316‐322.

Anderson 2005 {published data only}

Anderson, R M, M. M. Funnell, et al. Evaluating a problem‐based empowerment program for African Americans with diabetes: results of a randomized controlled trial. Ethnicity and Disease 2005;15(4):671‐8.

Bacardi‐Gascon 2004 {published data only}

Bacardi‐Gascon, M, P. Rosales‐Garay, et al. Effect of Diabetes Intervention Programs on Physical Activity among Migrant Mexican Women with Type 2 Diabetes. Diabetes Care 2004;27(2):616.

Baradaran 2006 {published data only}

Baradaran, H R, R. P. Knill‐Jones, et al. A controlled trial of the effectiveness of a diabetes education programme in a multi‐ethnic community in Glasgow [ISRCTN28317455]. BMC Public Health 2006;6:134.

Baran 1999 {published data only}

Baran, R W, K. Crumlish, et al. Improving outcomes of community‐dwelling older patients with diabetes through pharmacist counseling. American Journal of Health‐System Pharmacy 1999;56(15):1535‐1539.

Barcelo 2001 {published data only}

Barcelo, A, S. Robles, et al. An intervention to improve diabetes control in Chile. [Spanish]. Revista Panamericana de Salud Publica/Pan American Journal of Public Health. 2001;10(5):328‐333.

Barth 1991 {published data only}

Barth, R, L. V. Campbell, et al. Intensive education improves knowledge, compliance, and foot problems in type 2 diabetes,. Diabetic Medicine. 1991;8(2):111‐117.

Bloomgarden 1987 {published data only}

Bloomgarden, Z T, W. Karmally, et al. Randomized, controlled trial of diabetic patient education: Improved knowledge without improved metabolic status,. Diabetes Care 1987;10(3):263‐272.

Bradshaw 2006 {published data only}

Bradshaw, B G. The efficacy of a resiliency training program in adults with type 2 diabetes mellitus. Thesis Univeristy of Utah2006.

Browning 2003 {published data only}

Browning, C J, S. A. Thomas. Six‐month outcome data for the Good Life Club project: an outcomes study of diabetes self‐management.. Special Issue: The Management of Chronic Disease in Primary Care Settings2003; Vol. 9:192‐198.

Cabrera‐Pivaral 2000 {published data only}

Cabrera‐Pivaral, C E, G. Gonzalez‐Perez, et al. Effects of behavior‐modifying education in the metabolic profile of the type 2 diabetes mellitus patient. Journal of Diabetes & its Complications 2000;14(6):322‐6.

Chen 2003 {published data only}

Chen, Y S, W. C. Xu, et al. Significance of reinforcing management on limb salvage therapy in patients at high risk for diabetic foot. [Chinese],. Zhongguo Linchuang Kangfu 2003;7(18):2556‐2557.

Cleghorn 2004 {published data only}

Cleghorn, G D, M. Nguyen, et al. Practice‐based interventions to improve health care for Latinos with diabetes. Ethnicity & Disease Summer 2004;1:117‐121.

Clifford 2005 {published data only}

Clifford, R M, W. A. Davis, et al. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2005;28(4):771‐6.

Cooper 2003 {published data only}

Cooper, H, K. Booth, et al. Using combined research methods for exploring diabetes patient education. Patient Education & Counseling 2003;51(1):45‐52.

D'Eramo‐Melkus 1992 {published data only}

D'Eramo‐Melkus, G A, J. Wylie‐Rosett, et al. Metabolic impact of education in NIDDM. Diabetes Care 1992;15(7):864‐9.

De Weerdt, I., 1991 {published data only}

De Weerdt, I, A. P. Visser, et al. Randomized controlled multicentre evaluation of an education programme for insulin‐treated diabetic patients: Effects on metabolic control, quality of life, and costs of therapy,. Diabetic Medicine. 1991;8(4):338‐345.

Deakin 2006 {published data only}

Deakin, T A, J. E. Cade, et al. Structured patient education: the Diabetes X‐PERT Programme makes a difference. Diabetic Medicine 2006;23(9):944‐954.

Di Loreto 2003 {published data only}

Di Loreto, C, C. Fanelli, et al. Validation of a counseling strategy to promote the adoption and the maintenance of physical activity by type 2 diabetic subjects. Diabetes Care 2003;26(2):404‐8.

Dijkstra 2006 {published data only}

Dijkstra, R F, L. W. Niessen, et al. Patient‐centred and professional‐directed implementation strategies for diabetes guidelines: A cluster‐randomized trial‐based cost‐effectiveness analysis,. Diabetic Medicine 2006;23(2):164‐170.

Dongbo 2003 {published data only}

Dongbo, F, F. Hua, et al. Implementation and quantitative evaluation of chronic disease self‐management programme in Shanghai, China: Randomized controlled trial,. Bulletin of the World Health Organization 2003;81(3):174‐182.

Donohoe 2000 {published data only}

Donohoe, E, J. A. Fletton, et al. Improving foot care for people with diabetes mellitus ‐ A randomized controlled trial of an integrated care approach,. Diabetic Medicine 2000;17(8):581‐587.

Fan 1999 {published data only}

Fan, L, J. Zhu, et al. Effect of diabetic education on patients' knowledge and self‐management ability [Chinese]. Hong Kong Nursing Journal 1999;35(2):15‐8.

Fan, M. J., G. 2002 {published data only}

Fan, M J, G. H. Wu, et al. Effect evaluation of health education in 80 cases of type 2 diabetes,. Zhongguo Linchuang Kangfu 2002;6(21):3298.

Fornos 2006 {published data only}

Fornos, J A, N. F. Andres, et al. A pharmacotherapy follow‐up program in patients with type‐2 diabetes in community pharmacies in Spain. Pharmacy World & Science 2006;28(2):65‐72.

Fu 2003 {published data only}

Fu, D, H. Fu, et al. Implementation and quantitative evaluation of chronic disease self‐management programme in Shanghai, China: Randomized controlled trial. Bulletin of the World Health Organization 2003;81(3):174‐182.

Fukuda 1999 {published data only}

Fukuda H, M. Evaluation of a diabetes patient education program consisting of a three‐day hospitalization and a six‐month follow‐up by telephone counseling for mild type 2 diabetes and IGT. Environmental Health & Preventive Medicine 1999;4(3):122‐129.

Gabbay 2006 {published data only}

Gabbay, R A, I. Lendel, et al. Nurse case management improves blood pressure, emotional distress and diabetes complication screening,. Diabetes Research & Clinical Practice 2006;71(1):28‐35.

Gaede 2001 {published data only}

Gaede, P, M. Beck, et al. Limited impact of lifestyle education in patients with Type 2 diabetes mellitus and microalbuminuria: results from a randomized intervention study. Diabetic Medicine 2001;18(2):104‐8.

Gallegos 2006 {published data only}

Gallegos, E C, F. Ovalle‐Berumen, et al. Metabolic control of adults with type 2 diabetes mellitus through education and counseling. Journal of Nursing Scholarship 2006;38(4):344‐51.

Gary 2003 {published data only}

Gary, T L, L. R. Bone, et al. Randomized controlled trial of the effects of nurse case manager and community health worker interventions on risk factors for diabetes‐related complications in urban African Americans. Preventive Medicine 2003;37(1):23‐32.

Gentile 2004 {published data only}

Gentile, L, E. Borgo, et al. ROMEO: Rethink Organization to improve education and outcomes. A randomised controlled multicentre trial of group care for the management of type 2 diabetes. [Italian],. Giornale Italiano di Diabetologia e Metabolismo. 2004;24(1):9‐16.

Ghosh 2007 {published data only}

Ghosh, H A, A. Shaar, et al. Diabetes control in 3 villages in Palestine: A community‐based quality improvement intervention,. Journal of Ambulatory Care Management. 2007;30(1):74‐78.

Gilliland 2002 {published data only}

Gilliland, S S, S. P. Azen, et al. Strong in body and spirit: Lifestyle intervention for Native American adults with diabetes in New Mexico,. Diabetes Care 2002;25(1):78‐83.

Glasgow {published data only}

Glasgow Re, T. Nutrition education and social learning interventions for type II diabetes.. Diabetes care 1989;12(2):150‐2.

Hae 2005 {published data only}

Hae, M C, S. Mitrovich, et al. Proactive case management of high‐risk patients with type 2 diabetes mellitus by a clinical pharmacist: A randomized controlled trial. American Journal of Managed Care 2005;11(4):253‐260.

Hajdinjak 2003 {published data only}

Hajdinjak, D, M. Cokolic. Improvement of control of type 2 diabetes after patient education. Diabetes & Metabolism 2003;29:(Hors serie 2).

Hanefeld 1991 {published data only}

Hanefeld, M, S. Fischer, et al. Diabetes Intervention Study. Multi‐intervention trial in newly diagnosed NIDDM. 1991 Diabetes Care;14(4):308‐17.

Holtrop 2002 {published data only}

Holtrop, J S, J. Hickner, et al. "Sticking to it ‐‐ diabetes mellitus": a pilot study of an innovative behavior change program for women with type 2 diabetes. American Journal of Health Education 2002;33(3):161‐6.

Jayasuriya 2000 {published data only}

Jayasuriya, R, R. Griffiths, et al. Outcome assessment of a community based model of general practitioner care diabetes patients,. Practical Diabetes International 2000;17(6):179‐182.

Jones 2003 {published data only}

Jones, H, L. Edwards, et al. Changes in diabetes self‐care behaviors make a difference in glycemic control ‐ The diabetes stages of change (DiSC) study. Diabetes care 2003;26(3):732‐737.

Jungmann 1997 {published data only}

Jungmann, E, G. Jungmann, et al. Patient education of non‐insulin‐dependent diabetic patients. Effect of an ambulatory educational program on metabolism and risk factors. Fortschritte der Medizin 1997;115:20‐1.

Kirk 2004 {published data only}

Kirk, A, N. Mutrie, et al. Effects of a 12‐month activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes,. Diabetologia2004; Vol. 47, issue 5:821‐832.

Ko, S. H., K. 2007 {published data only}

Ko, S H, K. H. Song, et al. Long‐term effects of a structured intensive diabetes education programme (SIDEP) in patients with Type 2 diabetes mellitus ‐ A 4‐year follow‐up study,. Diabetic Medicine 2007;24(1):55‐62.

Korhonen 1987 {published data only}

Korhonen, T, M. Uusitupa, et al. Efficacy of dietary instructions in newly diagnosed non‐insulin‐dependent diabetic patients. Comparison of two different patient education regimens. Acta Medica Scandinavica 1987;222(4):323‐31.

Kronsbein 1988 {published data only}

Kronsbein, P, V. Jorgens, et al. Evaluation of a structured treatment and teaching programme on non‐insulin‐dependent diabetes. Lancet 1988;2:1407‐11.

Kulzer 2007 {published data only}

Kulzer, B, N. Hermanns, et al. Effects of self‐management training in Type 2 diabetes: a randomized, prospective trial. Diabetic Medicine 2007;24(4):415‐423.

Laitinen 1993 {published data only}

Laitinen Jh, A. Impact of intensified dietary therapy on energy and nutrient intakes and fatty acid composition of serum lipids in patients with recently diagnosed non‐insulin‐dependent diabetes mellitus.. Journal of the American Dietetic Association 1993;93(3):276‐83.

Li 2003 {published data only}

Li, X. Experiences of carrying out health education in type 2 diabetes patients [Chinese]. Chinese Nursing Research 2003;17(2B):195‐7.

Li, X., Y. Cao, 2003 {published data only}

Li, X, Y. Cao, et al. Effects of education on blood sugar and complications of 2 type diabetes,. Zhongguo Linchuang Kangfu 2003;7(3):509.

Litzelman 1993 {published data only}

Litzelman Dk, S. Reduction of lower extremity clinical abnormalities in patients with non‐insulin‐dependent diabetes mellitus. A randomized, controlled trial. Annals of internal medicine 1993;119(1):36‐41, 1993.

Lorig 2003 {published data only}

Lorig, K R, P. L. Ritter, et al. Hispanic chronic disease self‐management: a randomized community‐based outcome trial. Nursing Research 2003;52(6):361‐9.

Lou 2006 {published data only}

Lou, V W. Q, Y. Q. Zhang. Evaluating the effectiveness of a Participatory Empowerment Group for Chinese type 2 diabetes patients. Research on Social Work Practice 2006;16(5):491‐499.

Lozano 1999 {published data only}

Lozano, M L, M. J. Armale, et al. [The education of type‐2 diabetics: why not in groups?].[see comment][erratum appears in Aten Primaria 1999 Jul‐Aug;24(3):178]. Atencion Primaria 1999;24(3):485‐92.

Maislos 2004 {published data only}

Maislos, M, D. Weisman. Multidisciplinary approach to patients with poorly controlled type 2 diabetes mellitus: A prospective, randomized study,. Acta Diabetologica 2004;41(2):44‐48.

Martinus 2006 {published data only}

Martinus, R, R. Corban, et al. Effect of psychological intervention on exercise adherence in type 2 diabetic subjects. Annals of the New York Academy of Sciences 2006;1084:350‐60.

Mayer‐Davis 2004 {published data only}

Mayer‐Davis, E J, A. M. D'Antonio, et al. Pounds off with empowerment (POWER): A clinical trial of weight management strategies for black and white adults with diabetes who live in medically underserved rural communities,. American Journal of Public Health 2004;94(10):1736‐1742.

Mazzuca 1986 {published data only}

Mazzuca, S A, N. H. Moorman, et al. The Diabetes Education Study: A controlled trial of the effects of diabetes patient education,. Diabetes Care 1986;9(1):1‐10.

Mshelia 2007 {published data only}

Mshelia, D S, O. M. Akinosun, et al. Effect of increased patient‐physician contact time and health education in achieving diabetes mellitus management objectives in a resource‐poor environment. Singapore Medical Journal 2007;48(1):74‐9.

Neder 2003 {published data only}

Neder, S, P. Nadash, et al. Individualized education can improve foot care for patients with diabetes. Home Healthcare Nurse 2003;21(12):837‐40.

Odegard 2005 {published data only}

Odegard, P S, A. Goo, et al. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Annals of Pharmacotherapy 2005;39(3):433‐40.

Pedersen 2003 {published data only}

Pedersen, O, P. Gaede. Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: The Steno‐2 study,. Metabolism: Clinical & Experimental. 2003;52(8 Suppl 1):19‐23.

Pennings‐Van 1992 {published data only}

Pennings‐Van der Eerden, L, T. Ripken, et al. Evaluation of the impact of a patient education programme for NIDDM patients on knowledge, self‐care behaviour, metabolic control and lipid profiles. Gedrag & Gezondheid: Tijdschrift voor Psychologie en Gezondheid 1992;19(5):246‐260.

Philis‐Tsimikas 2004 {published data only}

Philis‐Tsimikas, A, C. Walker, et al. Improvement in diabetes care of underinsured patients enrolled in Project Dulce: A community‐based, culturally appropriate, nurse case management and peer education diabetes care model. Diabetes Care 2004;27(1):110‐115.

Pibernik‐Okanovi2004 {published data only}

Pibernik‐Okanovic, M, M. Prasek, et al. Effects of an empowerment‐based psychosocial intervention on quality of life and metabolic control in type 2 diabetic patients. Patient Education and Counseling 2004;52(2):193‐9.

Trento 2001 {published data only}

Trento M, Passera P, et al. Group visits improve metabolic control in type 2 diabetes: a 2‐year follow‐up. Diabetes Care 2001;24(6):995‐1000.

Wilson 1987 {published data only}

Wilson, W, C. Pratt, et al. The impact of diabetes education and peer support upon weight and glycemic control of elderly persons with noninsulin dependent diabetes mellitus (NIDDM). American Journal of Public Health 1987;77(5):634‐5.

Wolf 2004 {published data only}

Wolf, A M, M. R. Conaway, et al. Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study.[see comment]. Diabetes Care 2004;27(7):1570‐6.

Woollard 2003 {published data only}

Woollard, J, V. Burke, et al. Effects of general practice‐based nurse‐counselling on ambulatory blood pressure and antihypertensive drug prescription in patients at increased risk of cardiovascular disease. Journal of Human Hypertension 2003;17(10):689‐95.

Referencias adicionales

AADE 2003

AADE. Standards for Outcomes Measurement of Diabetes Self‐Management Education. Position Statement.. Diabetes Educator 2003;29(5):804‐16.

ADA 1999

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1999;22 Suppl 1:S5‐19.

ADA 2003

American Diabetes Association. Economic costs of diabetes in the US in 2002.. Diabetes Care 2003;26:917‐932.

Corabian 2001

Corabian P, Harstall C. Patient Diabetes Education in the Management of Adult Type 2 Diabetes. Health Technology Assessment ‐ Alberta Heritage Foundation for Medical Research. Alberta: Alberta Heritage Foundation for Medical Research, 2001; Vol. HTA 23 Series A, issue Feb:1‐90.

Davies 2008

Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial.. BMJ 2008;336(7642):491‐5.

Deakin 2005

Deakin T, McShane CE, Cade JE, Williams RDRR. Group based training for self‐management strategies in people with thype 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD003417.pub2]

Deakin 2006

Deakin TA, Cade JE, Williams R, Greenwood DC. Structured patient education: the diabetes X‐PERT Programme makes a difference. Diabetic Medicine 2006;23(9):944‐54.

Diabetes Atlas 2005

International Diabetes Federation. Diabetes Atlas. www.idf.org/e‐atlas.2005.

Eigenmann 2007

Eigenmann C, Colagiuri R. Outcomes and Indicators for Diabetes Education ‐ A National Consensus Position.. Diabetes Australia 2007;June:1‐54.

Ellis 2004

Ellis SE, Speroff T, Dittus RS, Brown A, Pichert JW, Elasy TA. Diabetes patient education: a meta‐analysis and meta‐regression. Patient Education & Counseling 2004;52(1):97‐105.

Funnell 2004

Funnell MM. Patient empowerment. Critical Care Nursing Quarterly 2004;27(2):201‐4.

Glasgow 1999

Glasgow R, Fisher E, Anderson B, LeGreca A, Marrero D, Johnson S, Rubin R, Cox D. Behavioural Science in Diabetes: Contributions and Opportunities. Diabetes Care 1999;22(5):832‐43.

Higgins 2003

Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analysis. BMJ 2003;327:557‐60.

Higgins 2005

Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd.

Holmes 2003

Holmes J, Gear E, Bottomley J, Gillam S, Murphy M, Williams R. Do people with type 2 diabetes and their carers lose income? (T2ARDIS‐4). Health Policy 2003;64(3):291‐6.

Jonsson 2002

Jonsson B. Revealing the cost of Type II diabetes in Europe. Diabetologia 2002;45:S5‐S12.

King 1998

King H, Aubert R, Herman W. Global Burden of diabetes, 1995‐2025 prevalence, numerical estimates and projections. Diabetes care 1998;21:1414‐1431.

Loveman 2003

Loveman E, Royle P, Waugh N. Specialist nurses in diabetes mellitus. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD003286]

Loveman 2008

Loveman E, Frampton GK, Clegg AJ. The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review. The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review.. Health Technol Assess Apr 2008;12(9):1‐136.

Moher 1999

Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta‐analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta‐analyses. Lancet 1999;354(9193):1896‐900.

Norris 2001

Norris SL, Engelgau MM, Narayan KMV. Effectiveness of self‐management training in type 2 diabetes. Diabetes Care 2001;24(3):561‐587.

Vermeire 2003

Vermeire E, Wens J, Van Royen P, Hernshaw H, Lindenmeyer A. Interventions for improving adherence to treatment recomendations in people with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD003638.pub2]

WHO 1980

WHO Expert Committee on Diabetes Mellitus. Geneva: World Health Organisation, 1980. Second report. Technical Report Series 646.

WHO 1985

WHO Expert Committee on Diabetes Mellitus. Geneva: World Health Organization, 1985. Technical Report Series 727..

WHO 1998

Alberti KM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its compliactions. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine 1998;15:539‐53.

Wild 2004

Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047‐1053.

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Campbell 1996

Methods

Locale: New South Wales, Australia.
Method of recruitment: Patients referred to a Diabetes Education Service (DES).
Inclusion/exclusion criteria: Diagnosed with type 2 diabetes, diagnosed for < 5 years, age < 80 yrs, speak, read and understand English, no previous formal instruction on diabetes care, not taking over 75% of the maximum dosage of oral hyopoglycaemic agents and not terminally ill.
Randomisation: No details on concealed allocation or method used.
Length of follow‐up from start of intervention: 6 and 12 months.
Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): No details given.
Power analysis: no
Intention to treat: no.
Informed consent: yes.
Approval: yes

Participants

Socio‐economic background: Not given. Could be judged by referral to the DES. 74% had education up to lower high school.
Baseline numbers: Recruited = not given; Eligible= 252; Randomised= 238; Control (Minimal) = 59; Control (Group education) = 65; Intervention (Individual education) = 57; Intervention (Behavioral) = 56.
End of study numbers at 6 months: Control (Minimal) = 17; Control (Group education) = 27; Intervention (Individual education) = 29; Intervention (Behavioral) = 43.
End of study numbers at 12 months: Control (Group education) = 19; Intervention (Individual education) = 25; Intervention (Behavioral) = 39.
Dropout rate: overall at 6 months 53%, at 12 months 35%.
Age (mean or range): 58.6 years.
Ethnicity: not given.
Sex: 52.3 % females.
Number of years of diabetes: mean = 0.54 years.
Proportion of Type 2: all type 2.
Treatment given: 37% on oral hypoglycaemic medication.
Average HbA1: Individual 12.2% Group 12.1%

Interventions

The study reported four interventions involving diet, exercise, use of oral hypoglycaemic agents, urine testing, foot care and recommendations to consult opthalmologist and podiatrist.
1. Minimal (Control) ‐ Two (nurse educator and dietician) 1‐ hr sessions. Same topics as intervention groups but in less detail.
2. Group education ‐ Two 1‐hr individual sessions + 3‐day course in small groups + two 2‐hr group follow up at 3 and 9 mo. Also opportunity to attend one 2‐hr lecture.
3. Individual education ‐ Two 1‐hr individual sessions + approx. monthly for 12 months. Same topics but greater details. Opportunity to attend a 2‐hr lecture.
4. Behavioral (Intervention) ‐ series of individual visits by nurse educator + random phone calls by nurse educator. Emphasis on cognitive‐behavioural strategies and cardiovascular risks (diet, exercise and smoking).
At 6 months, Extensive and Behavioural were compared with Minimal program as control. For 12‐month comparison, Extensive Group was used as control in this review as there were no outcome reported for Minimal Program.

Outcomes

HbA1, BMI kg/m2; fasting total cholesterol, mmol/l; HDL , mmol/l; cholesterol risk ratio ( total cholesterol /HDL); systolic BP, mmHg; diastolic BP, mmHg; knowledge test (DKN), 15‐point scale; satisfaction ,18 item scale developed by authors.

Notes

Group education had components in individual sessions. Group patients received more overall contact than all other groups. Participants in Minimal program were not measured at 12 months. Therefore for analysis only individual and group were used

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Dalmau 2003

Methods

Locale: Spain
Method of recruitment: Patients from primary care.
Inclusion/exclusion criteria: Diagnosed with type 2 diabetes at least six months before the start of trial and had not received group education. Those over 75 years, or having sensory psychological and/or physical deficiencies and those not monitored in primary care were excluded.
Randomisation: Unsure of concealment or method used.
Length of follow‐up from start of intervention: 12 months.
Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): unsure.
Power analysis: unsure.
Intention to treat: no.
Informed consent: unsure.
Approval: unsure.

Participants

Socio‐economic background: Unsure.
Baseline numbers: Recruited = 93; Eligible= 79; Randomised= 79; group= 38; Individual = 41.
End of study numbers: group= 35; Individual= 33.
Dropout rate: 14%.
Age: mean = 65 years.
Ethnicity: unclear.
Sex: 35% males in individual education and 64.7% males in group education
Number of years of diabetes: diagnosed at least 6 months prior to study
Proportion of Type 2: all.
Oral hypoglycaemics: individual 60% and group 51.4%
Average HbA1c at baseline: Intervention ‐ 6.6% and group 7.2%

Interventions

Control: Group education.
Intervention: Individual education.
Each received 3 sessions, seperated by one week, 40 minutes, content the same

Outcomes

HbA1c%; HDL cholesterol, mmol/l; LDL cholesterol, mmol/l; BMI, kg/m2; systolic BP, mmHg; diastolic BP, mmHg; diabetes knowledge.

Notes

There were almost twice as many women in Intervention group compared to that in Control group. Published in Spanish. Data extracted from summary, text and tables.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Goudswaard 2004

Methods

Locale: The Netherlands
Method of recruitment: Recruited from 57 practices, 78 GPs
Inclusion/exclusion criteria: Type 2 diabetes, treated by primary care only, aged less than 76 years, with HbA1c >= 7.0% while taking the maximum feasible dosages of two different oral hypoglycaemic agents. Excluded are those with severe co‐morbidity, not fluent in Dutch, requirement for insulin therapy in the short term on account of severe hyperglycaemic symptoms.
Randomisation: By independent trial centre. Method used was computer‐generated random assignment with blocks of 8 patients at a time.
Length of follow‐up from start of intervention: 6 and 18 months
Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)):
Power analysis: yes
Intention to treat: yes; missing values represented last previous value.
Informed consent: yes
Approval: yes

Participants

Socio‐economic background: Participants from all levels of community.
Sampling: Recruitment to randomisation =76.3%. Randomisation to completion of trial = 86.2%.
Baseline numbers: Recruited = 1810; Eligible = 76; Randomised = 58; Control = 30; Intervention = 28.
End of study numbers: Control = 26; Intervention = 24.
Dropout rate: 14%
Age: average = 60.5 years
Ethnicity: Dutch
Sex: 52 % females
Number of years of diabetes: 7.5 years.
Proportion of Type 2: all.
Medication: 22% on diet only, 12% on insulin,66% oral hypoglycaemic agents.
Average HbA1c ‐ Intervention 8.2%, Control 8.8%

Interventions

Intervention: Collaborative, mixed educational intervention by two diabetes nurses. Focus on diabetes, compliance with medication, importance of physical exercise, losing weight and nutritional advice. 6 sessions during the 6 month period, total contact time of approximately 2.5 hours

Control: Usual care by GP. GP instructed not to alter medication unless a patient developed severe hyperglycaemic symptoms

Outcomes

HbA1c, %. body weight

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Hawthorne 1997

Methods

Locale: UK.
Method of recruitment: Recruited through Manchester Diabetes Centre or one of 10 mini‐clinics.
Inclusion/exclusion criteria: British Pakistanis with Type 2 diabetes. Excluded if enrolled in another study, too ill, if they or spouse had received formal education in the last 6 months
Randomisation: Sequential and using concealed envelope and random number generator.
Length of follow‐up from start of intervention: 6 months
Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): unclear
Power analysis: yes
Intention to treat: no
Informed consent: yes
Approval: yes

Participants

Socio‐economic background: Pakistani migrant and many with little knowledge of English and many illiterate.
Baseline numbers: Recruited = na; Eligible= na; Randomised= 201; Control= 112; Intervention = 89.
End of study numbers: Control= 86; Intervention= 106.
Return to follow‐up rate: 95%
Age (mean or range): Intervention 52 years, control 54 years
Ethnicity: Pakistani
Sex: 46% males in intervention and 47% male in control group
Number of years of diabetes: unknown.
Proportion of Type 2: all.
HbA1c: Intervention 8.4% and control 8.6%

Interventions

Intervention: Face‐to‐face by diabetes nurse using flash cards on various topics (diabetic diet, glucose monitoring and diabetic complications). The educational services were offered in Punjabi or Urudu. 20 minutes with each patient

Control: usual care.

Outcomes

HbA1c, %; knowledge on complications; food knowledge score.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Hiss 2001

Methods

Locale: USA.
Method of recruitment: Through advertisements and announcement with offer of free & comprehensive diabetes evaluation. Two large and 2 small communities were targeted based on area codes.
Inclusion/exclusion criteria: Diagnosed with diabetes Type 2, and those with Type 1 were excluded.
Randomisation: No indication of concealed allocation but random number used.
Length of follow‐up from start of intervention: 12 months.
Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): not blinded.
Power analysis: no
Intention to treat: no
Informed consent: yes
Approval: yes

Participants

Socio‐economic background: Those who responded to the advertisement for the service or incentive or both.
Baseline numbers: Recruited = 431; Eligible= 376; Randomised= 376; Control= 190; Intervention = 186.
End of study numbers: Control= 156; Intervention= 158.
Return to follow‐up rate: 84%
Age (mean or range): Control = 64 years; Intervention = 65 years.
Ethnicity: not available
Sex: Control = 27% and Intervention = 12% females.
Number of years of diabetes: Control = 10 years and Intervention = 9 years.
Proportion of Type 2: all.
Average HbA1c: Intervention 7.7% & control 7.9%

Interventions

Control: usual care.
Intervention: Face‐to‐face or via telephone by specialist nurse educator. Approx 4 hours of professional time per patient
Individual education and counselling session to encourage the patient to consult physician about identified problem.
High risk subsets for each outcome were defined as follows: HbA1c >= 7.5%, cholesterol >= 6.22mmol/l, systolic blood pressure >= 140 mmHg and systolic blood pressure >= 90 mmHg.

Outcomes

HbA1c, %; total cholesterol, mmol/L; diastolic BP, mmHg; systolic BP, mmHg.

Notes

intervention timing not clear;

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Ko 2004

Methods

Locale: Hong Kong
Method of recruitment: from 3 regional diabetic centres in Hong Kong
Inclusion/exclusion criteria: HbA1c 8.1 ‐ 11%, age range 35 ‐ 70 years
Randomisation: coin tossing
Length of follow‐up from start of intervention: 1 year
Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): physicians blinded
Power analysis: yes
Intention to treat: no
Informed consent: not stated
Approval: not stated

Participants

Socio‐economic background:
Baseline numbers: 90 in each group
End of study numbers: 2 control patients defaulted follow‐up
Return to follow‐up rate: 99%
Age (mean or range): Intervention 55, control 56 years
Ethnicity: Chinese
Sex: Intervention 48.9% male, control group 38.6% male
Number of years of diabetes: not stated
Proportion of Type 2: all.
Average HbA1c: Intervention 8.6%, control 8.4%

Interventions

Both groups followed up every 10 ‐ 14 weeks
Intervention: 5 x 30 minute visits after follow‐up by physicians, by nurse educator, concentrated on CV risk factors
Control: same medical care except no nursing reinforcement

Outcomes

fasting glucose, HbA1c, body mass index, waist circumference, blood pressure and lipid profiles

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

D ‐ Not used

Rickheim 2002

Methods

Locale: USA.
Method of recruitment: Patients referred to Diabetes Centre by primary care provider over a 2‐year period from April 1997 to July 1999.
Inclusion/exclusion criteria: Type 2. Newly diagnosed or previously diagnosed but without prior formal diabetes education. Patients treated with medical nutritional therapy and /or medical therapy.
Randomisation: randomisation in blocks of 3 patients to Control or Intervention during first year and in the following year, in blocks of 10 patients. Method of concealment or allocation was unclear.
Length of follow‐up from start of intervention: 6 months.
Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): all unclear.
Power analysis: not presented.
Intention to treat: no.
Informed consent: yes
Approval: yes

Participants

Source of patients: referred by primary care providers. Newly diagnosed diabetes or no history of prior systematic diabetes education
Socio‐economic background: not clear.
Baseline numbers: Randomised= 170; Control= 87; Intervention = 83.
End of study numbers: Control= 43; Intervention= 49.
Retention to follow‐up: 54%
Age (mean or range): 52.5 years
Ethnicity: 93% Caucasians
Sex: 66% females
Number of years of diabetes: 0.9 years.
Proportion of Type 2: All
Average HbA1c: Group 9% and individual 8.2%

Interventions

General: Four sessions were given to both groups. 5‐7 hours. Contents covered topics on education including diet, glucose monitoring and foot care. Participants in control groups received in groups of 4 to 8. Individuals in intervention group had shorter sessions to cover the same material. Interventions in both settings emphasized empowering the patient, by increasing knowledge, facilitating self‐management behaviour change

Outcomes

HbA1c, %; weight, kg; BMI, kg/m2; knowledge test (14pts); exercise (times/week); exercise duration (min/week); ATT‐19 ‐ Psychosocial adjustment and attitudes towards diabetes using 19‐point score; SF‐36 mental scale that measured mental health related quality of life; SF‐36 physical scale that measured physical health related quality of life.

Notes

Allocation in blocks of 6 or 10 may be biased. Groups attending clinic may be relatives, friends of similar socio‐economic background.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Shibayama 2007

Methods

Locale: Japan
Method of recruitment: outpatients of Department of diabetes and Metabolism, University Hospital.
Inclusion/exclusion criteria: adults, between ages of 20 ‐ 75, diagnosed with type 2 diabetes; HbA1c between 6.5% and 8.5%, who could not use insulin.
Randomisation: randomised but no details on concealment or methods.
Length of follow‐up from start of intervention: 1 year
Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): not blinded.
Power analysis: yes with 64 patients in each group, there was an 80% power to detect 0.5% difference in the change in HbA1c
Intention to treat: no.
Informed consent: not stated
Approval: Yes

Participants

Socio‐economic background: not stated
Baseline numbers: intervention 67 and control 67
End of study numbers at 12 months: intervention 59 control 61
Dropout rate: 10%
Age (mean or range): Intervention 61, Control 62
Ethnicity: Japanese
Sex: 65% males
Number of years of diabetes: mean = intervention 10 years, control 13 years.
Proportion of Type 2: all.
Treatment given: 89.6% on oral hypoglycaemic medication in intervention and 82.1% in control
Average HbA1c: Individual 7.3% Group 7.4%

Interventions

Intervention: received normal medical consultation and one‐to‐one counselling with a certified expert nurse at monthly hospital visits for 1 year. Features are patient participation in goal setting, personalized strategies and goal setting.
Control: received usual care by same practitioners at hospital clinic

Outcomes

HbA1c, HRQOL with SF‐36Japanese Version, PAID , cognitive modification (3 items), behavioural modification (1 item) and overall satisfaction with counselling (1 item)

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Whittemore 2004

Methods

Locale: USA.
Method of recruitment: Patients enrolled at single diabetes centre.
Inclusion/exclusion criteria: Females, diagnosed with type 2 diabetes; 30 to 70 yrs age; cleared for exercise by primary care provider; had no advanced complications of diabetes; HbA1c >7%; fluent in English and had previously participated in diabetes education.
Randomisation: randomised but no details on concealment or methods.
Length of follow‐up from start of intervention: 6 months.
Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): all unclear.
Power analysis: no.
Intention to treat: no.
Informed consent: yes.
Approval: yes.

Participants

Socio‐economic background: wide cover, low to middle income, mean of 12.6 yrs of education.
Baseline numbers: Recruited = 81; Eligible= 53; Randomised= 53; Control= 24; Intervention = 29.
End of study numbers: Control= 23; Intervention= 26.
Retention to follow‐up rate: 92%
Age (mean or range): 57.6 years
Ethnicity: 89% white, 11% Hispanic.
Sex: all females
Number of years of diabetes: 2.7 years.
Proportion of Type 2: all.
Mean HbA1c 7.7%

Interventions

Control: standard diabetes care at 3 ‐ 4 month intervals. Providers nurse practitioners, internists, endocrinologists and family practice specialists
Intervention: Individualised 6 nurse‐coaching sessions over 6 months. Included topics were assessment, education reinforcement (cognitive component), problem solving (behavioural component) and psychosocial support (affective component).

Outcomes

HbA1c, %; BMI, kg/m2; self management on diet, 5‐point scale; self management on exercise, min/mo; distress‐ PAID score; integration ‐ TDQ score., treatment satisfaction DTSQc

HbA1c DCA 2000 analyzer

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

High risk

C ‐ Inadequate

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Aas 2005

Mixed individual and group education sessions

Anderson 2005

Primarily group education

Bacardi‐Gascon 2004

Not a randomised controlled trial/ controlled trial

Baradaran 2006

Primarily group education

Baran 1999

Not a randomised controlled trial/ controlled trial

Barcelo 2001

Mixed type 1/ type 2

Barth 1991

Primarily group education

Bloomgarden 1987

Primarily group education

Bradshaw 2006

Primarily group education

Browning 2003

Not a randomised controlled trial/ controlled trial

Cabrera‐Pivaral 2000

Primarily group education

Chen 2003

Primarily foot care intervention

Cleghorn 2004

Not a randomised controlled trial/ controlled trial

Clifford 2005

Managed care ‐ pharmacy

Cooper 2003

Primarily group education

D'Eramo‐Melkus 1992

Mixed individual and group education sessions

De Weerdt, I., 1991

Primarily group education

Deakin 2006

Control group non standardized individual education

Di Loreto 2003

Primarily physical activity intervention

Dijkstra 2006

Education of professionals

Dongbo 2003

Primarily group education

Donohoe 2000

Education of professionals

Fan 1999

Mixed individual and group education sessions

Fan, M. J., G. 2002

Not a randomised controlled trial/ controlled trial

Fornos 2006

Managed care ‐ pharmacy

Fu 2003

Primarily group education

Fukuda 1999

Mixed individual and group education sessions

Gabbay 2006

Managed care

Gaede 2001

Mixed individual and group education sessions

Gallegos 2006

Mixed individual and group education sessions

Gary 2003

Managed care

Gentile 2004

Primarily group education

Ghosh 2007

Not randomised controlled trial/ controlled trial

Gilliland 2002

Not a randomised controlled trial/ controlled trial

Glasgow

Primarily group education

Hae 2005

Managed care ‐ pharmacy

Hajdinjak 2003

Not a randomised controlled trial/ controlled trial

Hanefeld 1991

Mixed individual and group education sessions

Holtrop 2002

Primarily group education

Jayasuriya 2000

Not a randomised controlled trial/ controlled trial

Jones 2003

Education not face to face

Jungmann 1997

Not a randomised controlled trial/ controlled trial

Kirk 2004

Primarily physical activity intervention

Ko, S. H., K. 2007

Primarily group education

Korhonen 1987

Primarily dietary intervention

Kronsbein 1988

Not a randomised controlled trial/ controlled trial

Kulzer 2007

Mixed individual and group education sessions

Laitinen 1993

Primarily dietary intervention

Li 2003

Mixed individual and group education sessions

Li, X., Y. Cao, 2003

Not a randomised controlled trial/ controlled trial

Litzelman 1993

Not individual education

Lorig 2003

Not specific for diabetes

Lou 2006

Primarily group education

Lozano 1999

Primarily group education

Maislos 2004

Managed care

Martinus 2006

Primarily physical activity intervention

Mayer‐Davis 2004

Mixed individual and group education sessions

Mazzuca 1986

Mixed individual and group education sessions

Mshelia 2007

Mixed individual and group education sessions

Neder 2003

References 'Corbett 2003' which evaluated foot care

Odegard 2005

Managed care ‐ pharmacy

Pedersen 2003

Mixed individual and group education sessions

Pennings‐Van 1992

Primarily group education

Philis‐Tsimikas 2004

Mixed individual and group education sessions

Pibernik‐Okanovi2004

Not a randomised controlled trial/ controlled trial, group education

Trento 2001

Primarily group education

Wilson 1987

Primarily group education

Wolf 2004

Primarily group education

Woollard 2003

Not specific to diabetes

Data and analyses

Open in table viewer
Comparison 1. Individual diabetes education programme versus usual care

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 HbA1c: 6 ‐ 9 months (r = 0.75) Show forest plot

3

295

Mean Difference (IV, Fixed, 95% CI)

‐0.23 [‐0.49, 0.03]

Analysis 1.1

Comparison 1 Individual diabetes education programme versus usual care, Outcome 1 HbA1c: 6 ‐ 9 months (r = 0.75).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 1 HbA1c: 6 ‐ 9 months (r = 0.75).

1.1 Both Sexes

2

246

Mean Difference (IV, Fixed, 95% CI)

‐0.33 [‐0.67, 0.02]

1.2 Women

1

49

Mean Difference (IV, Fixed, 95% CI)

‐0.1 [‐0.50, 0.30]

2 HbA1c: 12 ‐ 18 months (r = 0.75) Show forest plot

4

632

Mean Difference (IV, Fixed, 95% CI)

‐0.08 [‐0.25, 0.08]

Analysis 1.2

Comparison 1 Individual diabetes education programme versus usual care, Outcome 2 HbA1c: 12 ‐ 18 months (r = 0.75).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 2 HbA1c: 12 ‐ 18 months (r = 0.75).

3 HbA1c: 6 ‐ 9 months (r = 0.25) Show forest plot

3

295

Mean Difference (IV, Fixed, 95% CI)

‐0.26 [‐0.69, 0.16]

Analysis 1.3

Comparison 1 Individual diabetes education programme versus usual care, Outcome 3 HbA1c: 6 ‐ 9 months (r = 0.25).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 3 HbA1c: 6 ‐ 9 months (r = 0.25).

3.1 Both Sexes

2

246

Mean Difference (IV, Fixed, 95% CI)

‐0.37 [‐0.92, 0.18]

3.2 Women

1

49

Mean Difference (IV, Fixed, 95% CI)

‐0.1 [‐0.78, 0.58]

4 HbA1c: 12 ‐ 18 months (r = 0.25) Show forest plot

4

632

Mean Difference (IV, Fixed, 95% CI)

‐0.05 [‐0.25, 0.14]

Analysis 1.4

Comparison 1 Individual diabetes education programme versus usual care, Outcome 4 HbA1c: 12 ‐ 18 months (r = 0.25).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 4 HbA1c: 12 ‐ 18 months (r = 0.25).

5 BMI: 6 ‐ 9 months (r = 0.75) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.5

Comparison 1 Individual diabetes education programme versus usual care, Outcome 5 BMI: 6 ‐ 9 months (r = 0.75).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 5 BMI: 6 ‐ 9 months (r = 0.75).

5.1 Women

1

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

6 BMI: 12 ‐ 18 months (r = 0.75) Show forest plot

2

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 1.6

Comparison 1 Individual diabetes education programme versus usual care, Outcome 6 BMI: 12 ‐ 18 months (r = 0.75).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 6 BMI: 12 ‐ 18 months (r = 0.75).

7 Systolic blood pressure: 12 ‐ 18 months (r = 0.75) Show forest plot

3

625

Mean Difference (IV, Fixed, 95% CI)

‐1.86 [‐4.68, 0.95]

Analysis 1.7

Comparison 1 Individual diabetes education programme versus usual care, Outcome 7 Systolic blood pressure: 12 ‐ 18 months (r = 0.75).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 7 Systolic blood pressure: 12 ‐ 18 months (r = 0.75).

8 Diastolic blood pressure: 12 ‐ 18 months (r = 0.75) Show forest plot

3

624

Mean Difference (IV, Fixed, 95% CI)

‐1.61 [‐3.22, 0.00]

Analysis 1.8

Comparison 1 Individual diabetes education programme versus usual care, Outcome 8 Diastolic blood pressure: 12 ‐ 18 months (r = 0.75).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 8 Diastolic blood pressure: 12 ‐ 18 months (r = 0.75).

9 Total cholesterol: 12 ‐ 18 months Show forest plot

3

627

Mean Difference (IV, Fixed, 95% CI)

‐0.03 [‐0.16, 0.10]

Analysis 1.9

Comparison 1 Individual diabetes education programme versus usual care, Outcome 9 Total cholesterol: 12 ‐ 18 months.

Comparison 1 Individual diabetes education programme versus usual care, Outcome 9 Total cholesterol: 12 ‐ 18 months.

10 Mean baseline HbA1c> 8% Show forest plot

3

424

Mean Difference (IV, Fixed, 95% CI)

‐0.31 [‐0.54, ‐0.09]

Analysis 1.10

Comparison 1 Individual diabetes education programme versus usual care, Outcome 10 Mean baseline HbA1c> 8%.

Comparison 1 Individual diabetes education programme versus usual care, Outcome 10 Mean baseline HbA1c> 8%.

Open in table viewer
Comparison 2. Individual diabetes education programme versus group education programme

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 HbA1c: 6 ‐ 9 months (r = 0.75) Show forest plot

2

148

Mean Difference (IV, Fixed, 95% CI)

0.81 [0.34, 1.29]

Analysis 2.1

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 1 HbA1c: 6 ‐ 9 months (r = 0.75).

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 1 HbA1c: 6 ‐ 9 months (r = 0.75).

2 HbA1c: 12 ‐ 18 months Show forest plot

2

112

Mean Difference (IV, Fixed, 95% CI)

0.03 [‐0.02, 0.08]

Analysis 2.2

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 2 HbA1c: 12 ‐ 18 months.

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 2 HbA1c: 12 ‐ 18 months.

3 HbA1c: 6 ‐ 9 months (r = 0.25) Show forest plot

2

148

Mean Difference (IV, Fixed, 95% CI)

0.83 [0.19, 1.47]

Analysis 2.3

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 3 HbA1c: 6 ‐ 9 months (r = 0.25).

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 3 HbA1c: 6 ‐ 9 months (r = 0.25).

4 BMI: 6 ‐ 9 months (r = 0.75) Show forest plot

2

169

Mean Difference (IV, Fixed, 95% CI)

‐0.11 [‐0.87, 0.65]

Analysis 2.4

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 4 BMI: 6 ‐ 9 months (r = 0.75).

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 4 BMI: 6 ‐ 9 months (r = 0.75).

5 BMI: 12 ‐ 18 months (r = 0.75) Show forest plot

2

123

Mean Difference (IV, Fixed, 95% CI)

‐0.01 [‐0.75, 0.73]

Analysis 2.5

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 5 BMI: 12 ‐ 18 months (r = 0.75).

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 5 BMI: 12 ‐ 18 months (r = 0.75).

6 Systolic blood pressure: 12 ‐ 18 months Show forest plot

2

95

Mean Difference (IV, Fixed, 95% CI)

4.12 [‐4.09, 12.32]

Analysis 2.6

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 6 Systolic blood pressure: 12 ‐ 18 months.

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 6 Systolic blood pressure: 12 ‐ 18 months.

7 Diastolic blood pressure: 12 ‐ 18 months (r = 0.75) Show forest plot

2

95

Mean Difference (IV, Fixed, 95% CI)

1.52 [‐4.07, 7.11]

Analysis 2.7

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 7 Diastolic blood pressure: 12 ‐ 18 months (r = 0.75).

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 7 Diastolic blood pressure: 12 ‐ 18 months (r = 0.75).

8 Total cholesterol: 12 ‐ 18 months Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 2.8

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 8 Total cholesterol: 12 ‐ 18 months.

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 8 Total cholesterol: 12 ‐ 18 months.

Amended QUOROM (quality of reporting of meta‐analyses) flow‐chart of study selection
Figuras y tablas -
Figure 1

Amended QUOROM (quality of reporting of meta‐analyses) flow‐chart of study selection

Comparison 1 Individual diabetes education programme versus usual care, Outcome 1 HbA1c: 6 ‐ 9 months (r = 0.75).
Figuras y tablas -
Analysis 1.1

Comparison 1 Individual diabetes education programme versus usual care, Outcome 1 HbA1c: 6 ‐ 9 months (r = 0.75).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 2 HbA1c: 12 ‐ 18 months (r = 0.75).
Figuras y tablas -
Analysis 1.2

Comparison 1 Individual diabetes education programme versus usual care, Outcome 2 HbA1c: 12 ‐ 18 months (r = 0.75).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 3 HbA1c: 6 ‐ 9 months (r = 0.25).
Figuras y tablas -
Analysis 1.3

Comparison 1 Individual diabetes education programme versus usual care, Outcome 3 HbA1c: 6 ‐ 9 months (r = 0.25).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 4 HbA1c: 12 ‐ 18 months (r = 0.25).
Figuras y tablas -
Analysis 1.4

Comparison 1 Individual diabetes education programme versus usual care, Outcome 4 HbA1c: 12 ‐ 18 months (r = 0.25).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 5 BMI: 6 ‐ 9 months (r = 0.75).
Figuras y tablas -
Analysis 1.5

Comparison 1 Individual diabetes education programme versus usual care, Outcome 5 BMI: 6 ‐ 9 months (r = 0.75).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 6 BMI: 12 ‐ 18 months (r = 0.75).
Figuras y tablas -
Analysis 1.6

Comparison 1 Individual diabetes education programme versus usual care, Outcome 6 BMI: 12 ‐ 18 months (r = 0.75).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 7 Systolic blood pressure: 12 ‐ 18 months (r = 0.75).
Figuras y tablas -
Analysis 1.7

Comparison 1 Individual diabetes education programme versus usual care, Outcome 7 Systolic blood pressure: 12 ‐ 18 months (r = 0.75).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 8 Diastolic blood pressure: 12 ‐ 18 months (r = 0.75).
Figuras y tablas -
Analysis 1.8

Comparison 1 Individual diabetes education programme versus usual care, Outcome 8 Diastolic blood pressure: 12 ‐ 18 months (r = 0.75).

Comparison 1 Individual diabetes education programme versus usual care, Outcome 9 Total cholesterol: 12 ‐ 18 months.
Figuras y tablas -
Analysis 1.9

Comparison 1 Individual diabetes education programme versus usual care, Outcome 9 Total cholesterol: 12 ‐ 18 months.

Comparison 1 Individual diabetes education programme versus usual care, Outcome 10 Mean baseline HbA1c> 8%.
Figuras y tablas -
Analysis 1.10

Comparison 1 Individual diabetes education programme versus usual care, Outcome 10 Mean baseline HbA1c> 8%.

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 1 HbA1c: 6 ‐ 9 months (r = 0.75).
Figuras y tablas -
Analysis 2.1

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 1 HbA1c: 6 ‐ 9 months (r = 0.75).

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 2 HbA1c: 12 ‐ 18 months.
Figuras y tablas -
Analysis 2.2

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 2 HbA1c: 12 ‐ 18 months.

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 3 HbA1c: 6 ‐ 9 months (r = 0.25).
Figuras y tablas -
Analysis 2.3

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 3 HbA1c: 6 ‐ 9 months (r = 0.25).

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 4 BMI: 6 ‐ 9 months (r = 0.75).
Figuras y tablas -
Analysis 2.4

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 4 BMI: 6 ‐ 9 months (r = 0.75).

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 5 BMI: 12 ‐ 18 months (r = 0.75).
Figuras y tablas -
Analysis 2.5

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 5 BMI: 12 ‐ 18 months (r = 0.75).

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 6 Systolic blood pressure: 12 ‐ 18 months.
Figuras y tablas -
Analysis 2.6

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 6 Systolic blood pressure: 12 ‐ 18 months.

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 7 Diastolic blood pressure: 12 ‐ 18 months (r = 0.75).
Figuras y tablas -
Analysis 2.7

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 7 Diastolic blood pressure: 12 ‐ 18 months (r = 0.75).

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 8 Total cholesterol: 12 ‐ 18 months.
Figuras y tablas -
Analysis 2.8

Comparison 2 Individual diabetes education programme versus group education programme, Outcome 8 Total cholesterol: 12 ‐ 18 months.

Comparison 1. Individual diabetes education programme versus usual care

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 HbA1c: 6 ‐ 9 months (r = 0.75) Show forest plot

3

295

Mean Difference (IV, Fixed, 95% CI)

‐0.23 [‐0.49, 0.03]

1.1 Both Sexes

2

246

Mean Difference (IV, Fixed, 95% CI)

‐0.33 [‐0.67, 0.02]

1.2 Women

1

49

Mean Difference (IV, Fixed, 95% CI)

‐0.1 [‐0.50, 0.30]

2 HbA1c: 12 ‐ 18 months (r = 0.75) Show forest plot

4

632

Mean Difference (IV, Fixed, 95% CI)

‐0.08 [‐0.25, 0.08]

3 HbA1c: 6 ‐ 9 months (r = 0.25) Show forest plot

3

295

Mean Difference (IV, Fixed, 95% CI)

‐0.26 [‐0.69, 0.16]

3.1 Both Sexes

2

246

Mean Difference (IV, Fixed, 95% CI)

‐0.37 [‐0.92, 0.18]

3.2 Women

1

49

Mean Difference (IV, Fixed, 95% CI)

‐0.1 [‐0.78, 0.58]

4 HbA1c: 12 ‐ 18 months (r = 0.25) Show forest plot

4

632

Mean Difference (IV, Fixed, 95% CI)

‐0.05 [‐0.25, 0.14]

5 BMI: 6 ‐ 9 months (r = 0.75) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

5.1 Women

1

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

6 BMI: 12 ‐ 18 months (r = 0.75) Show forest plot

2

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

7 Systolic blood pressure: 12 ‐ 18 months (r = 0.75) Show forest plot

3

625

Mean Difference (IV, Fixed, 95% CI)

‐1.86 [‐4.68, 0.95]

8 Diastolic blood pressure: 12 ‐ 18 months (r = 0.75) Show forest plot

3

624

Mean Difference (IV, Fixed, 95% CI)

‐1.61 [‐3.22, 0.00]

9 Total cholesterol: 12 ‐ 18 months Show forest plot

3

627

Mean Difference (IV, Fixed, 95% CI)

‐0.03 [‐0.16, 0.10]

10 Mean baseline HbA1c> 8% Show forest plot

3

424

Mean Difference (IV, Fixed, 95% CI)

‐0.31 [‐0.54, ‐0.09]

Figuras y tablas -
Comparison 1. Individual diabetes education programme versus usual care
Comparison 2. Individual diabetes education programme versus group education programme

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 HbA1c: 6 ‐ 9 months (r = 0.75) Show forest plot

2

148

Mean Difference (IV, Fixed, 95% CI)

0.81 [0.34, 1.29]

2 HbA1c: 12 ‐ 18 months Show forest plot

2

112

Mean Difference (IV, Fixed, 95% CI)

0.03 [‐0.02, 0.08]

3 HbA1c: 6 ‐ 9 months (r = 0.25) Show forest plot

2

148

Mean Difference (IV, Fixed, 95% CI)

0.83 [0.19, 1.47]

4 BMI: 6 ‐ 9 months (r = 0.75) Show forest plot

2

169

Mean Difference (IV, Fixed, 95% CI)

‐0.11 [‐0.87, 0.65]

5 BMI: 12 ‐ 18 months (r = 0.75) Show forest plot

2

123

Mean Difference (IV, Fixed, 95% CI)

‐0.01 [‐0.75, 0.73]

6 Systolic blood pressure: 12 ‐ 18 months Show forest plot

2

95

Mean Difference (IV, Fixed, 95% CI)

4.12 [‐4.09, 12.32]

7 Diastolic blood pressure: 12 ‐ 18 months (r = 0.75) Show forest plot

2

95

Mean Difference (IV, Fixed, 95% CI)

1.52 [‐4.07, 7.11]

8 Total cholesterol: 12 ‐ 18 months Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Figuras y tablas -
Comparison 2. Individual diabetes education programme versus group education programme